Описание
Risk of bias assessment for randomized controlled trials included in the PRP-FAGA systematic review. Quality evaluation across multiple domains indicates the overall strength of available evidence.
Figure 2
ChartSource Paper
Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature.Cite This Figure
![Figure 2: Risk of bias assessment for randomized controlled trials included in the PRP-FAGA systematic review. Quality evaluation across multiple domains indicates the overall strength of available evidence.]() > Source: Santo Raffaele Mercuri et al. "Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment fo." *Medicina (Kaunas, Lithuania)*, 2021. PMID: [33806169](https://pubmed.ncbi.nlm.nih.gov/33806169/)
<figure> <img src="" alt="Risk of bias assessment for randomized controlled trials included in the PRP-FAGA systematic review. Quality evaluation across multiple domains indicates the overall strength of available evidence." /> <figcaption>Figure 2. Risk of bias assessment for randomized controlled trials included in the PRP-FAGA systematic review. Quality evaluation across multiple domains indicates the overall strength of available evidence.<br> Source: Santo Raffaele Mercuri et al. "Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment fo." <em>Medicina (Kaunas, Lithuania)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33806169/">33806169</a></figcaption> </figure>